Welcome to chemicalbook!
400-158-6606
Inquriy
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

ChemicalBook >> CAS DataBase List >> 1-(4-bromophenyl)pyrimidine-2,4,6(1H,3H,5H)-trione

1-(4-bromophenyl)pyrimidine-2,4,6(1H,3H,5H)-trione

1-(4-bromophenyl)pyrimidine-2,4,6(1H,3H,5H)-trione price.
  • $361 - $1363
  • Product name: 1-(4-bromophenyl)pyrimidine-2,4,6(1H,3H,5H)-trione
  • CAS: 251468-84-5
  • MF: C10H7BrN2O3
  • MW: 283.08
  • EINECS:-0
  • MDL Number:MFCD00552518
  • Synonyms:1-(4-bromophenyl)pyrimidine-2,4,6(1H,3H,5H)-trione;1-(4-bromophenyl)-1,3-diazinane-2,4,6-trione;2,4,6(1H,3H,5H)-Pyrimidinetrione, 1-(4-bromophenyl)-
3 prices
Selected condition:
Brand
  • Chemenu
Package
  • 100mg
  • 250mg
  • 1g
  • ManufacturerChemenu
  • Product numberCM337590
  • Product description1-(4-Bromophenyl)-1,3-diazinane-2,4,6-trione 95%+
  • Packaging1g
  • Price$1363
  • Updated2021-12-16
  • Buy
  • ManufacturerChemenu
  • Product numberCM337590
  • Product description1-(4-Bromophenyl)-1,3-diazinane-2,4,6-trione 95%+
  • Packaging250mg
  • Price$491
  • Updated2021-12-16
  • Buy
  • ManufacturerChemenu
  • Product numberCM337590
  • Product description1-(4-Bromophenyl)-1,3-diazinane-2,4,6-trione 95%+
  • Packaging100mg
  • Price$361
  • Updated2021-12-16
  • Buy
Manufacturer Product number Product description Packaging Price Updated Buy
Chemenu CM337590 1-(4-Bromophenyl)-1,3-diazinane-2,4,6-trione 95%+ 1g $1363 2021-12-16 Buy
Chemenu CM337590 1-(4-Bromophenyl)-1,3-diazinane-2,4,6-trione 95%+ 250mg $491 2021-12-16 Buy
Chemenu CM337590 1-(4-Bromophenyl)-1,3-diazinane-2,4,6-trione 95%+ 100mg $361 2021-12-16 Buy

Properties

Density :1.732±0.06 g/cm3(Predicted)
pka :3.98±0.40(Predicted)

Safety Information

Symbol(GHS):
Signal word:
Hazard statements:
Code Hazard statements Hazard class Category Signal word Pictogram P-Codes
Precautionary statements:

Description

1-(4-Bromophenyl)-1,3-diazinane-2,4,6-trione is used in the optimization of 5-arylidene barbiturates as potent, selective, reversible LSD1 inhibitors for the treatment of acute promyelocytic leukemia